| Affiliation: | 1. Centre René Gauducheau, Medical Oncology Department, Saint-Herblain, France;2. Department of Radiation Oncology, Gustave Roussy, Villejuif, France;3. University Lille, Inserm, U1189 - ONCO-THAI - Assisted Laser Therapy and Immunotherapy for Oncology, 59000 Lille, France;4. Institut Bergonié, Medical Oncology Department, Bordeaux, France;5. Centre Léon Bérard, Department of Pediatric Oncology, Lyon, France;6. Centre Léon Bérard, Department of radiotherapy, Lyon, France;7. Cancer centre Léon Bérard, Santé-Individu-société EA-INSERM 4129, Lyon, France;8. Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France;9. Institut Curie, Medical Oncology Department, Paris, France;10. Centre Oscar Lambret, Department of Pediatric Oncology, Lille, France;11. Oncology Radiotherapy Institut de Cancérologie de Lorraine, Vand?uvre-lès-Nancy, France;12. Medical Oncology Department, Gustave Roussy, Villejuif, France;13. Department of Pediatric Oncology, Institut Curie, Paris, France;14. Medical Oncology Department, Centre Léon-Bérard, Lyon, France;1. Institut Gustave-Roussy, Sorbonne Université, service d’oncologie digestive, 94800 Villejuif, France;2. Centre hospitalier universitaire de Rennes, centre Eugène-Marquis, service d’oncologie digestive, 35000 Rennes, France;1. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy;2. Department of Gynecologic Oncology, Department of Obstetrics and Gynecology and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany;3. Department of Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron, Barcelona, Spain;4. Medical Oncology, San Salvatore Hospital, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;5. Division of Cancer and Surgery, Imperial College, London, UK;6. Department of Medical Oncology, Arnau de Vilanova Hospital, Valencia, Spain;1. Laboratoire d’optique et biosciences, Ecole Polytechnique, CNRS, Inserm, Institut Polytechnique de Paris, 91128 Palaiseau cedex, France;2. Université Sorbonne Paris-Nord, Inserm U978, 93017 Bobigny, France;3. Université de Paris, Inserm UMR-S 1124, équipe: homéostasie cellulaire, cancer, et thérapies, Inserm US36/CNRS UMS 2009, BioMedTech Facilities, 75006 Paris, France;1. Hôpital Saint-Louis, unité d’hématologie adolescents et jeunes adultes, 75010 Paris, France;2. Université Paris Diderot, institut universitaire d’hématologie, unité de recherche clinique appliquée à l’hématologie, EA-3518, 75010 Paris, France;1. Département de radiothérapie, Institut de cancérologie de l’Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain, France;2. Institut Curie, Université PSL, CNRS, Inserm, UMR 3347;3. Université Paris Sud, Université Paris-Saclay, 91405 Orsay, France;4. Centre de Recherche en Cancéro-Immunologie Nantes/Angers (CRCINA, UMR 892 Inserm), Institut de Recherche en Santé de l’Université de Nantes, Nantes cedex 1, France |
